APR 11, 2017 10:05 AM PDT

Battling the Cancer Takeover of Immune Cells

WRITTEN BY: Kara Marker

An overwhelming majority of cancer deaths are in some way connected to metastasis even though the immune system is rather effective at scouring the bloodstream for traveling cancer cells. This is because cancer cells have found a way around the ever-watching eye of the immune system, by seizing control of myeloid-derived suppressive cells (MDSCs) from the bone marrow.

Credit: Phil Jones, Senior Augusta University Photographer

"There is a very intricate balance in the immune system that is usually anti-tumorigenic, meaning it eliminates tumors, but in some cases, if this balance is altered, these cells may actually help tumors grow and develop into full-blown metastatic disease," explained Hasan Korkaya, PhD from the Medical College of Georgia at Augusta University.

MDSCs are conveniently capable of suppressing the immune response. While immune regulation is vital in some situations, cancer cells take advantage of MDSCs, using their “powers” for “evil” instead of “good.” MDSCs are found in high levels in mouse models and humans with cancer, and researchers from the Medical College of Georgia are working on unveiling the role of MDSCs in cancer metastasis.

Cancer cells secrete cytokines just like the immune system to communicate with MDSCs, and two different types of MDSCs are evidently useful to the cancer agenda.

  • Monocytic cells facilitate the tumor cell transition into a stem cell-like state to enable them to leave the primary tumor, enter the bloodstream, travel to a new area of the body, and set up camp

  • Granulocytic cells expedite the transition back to cancer cells and the multiplication process to build a new population of tumors

The therapeutic plan of attack is to “re-school” MDSCs to shift their loyalty back to the immune system, attacking cancer cells instead of protecting them. Additionally, researchers are interested in identifying and targeting cytokines used by cancer cells to communicate with MDSCs, literally killing the messenger.

The present study was published in the journal Nature Communications.

Source: Medical College of Georgia at Augusta University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 19, 2020
FEB 19, 2020
Rainbow trout hold the key to unravelling immunological mysteries
What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from th ...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Top 5 Candidates for Coronavirus Vaccine Around the World
It’s easy to complain about the role of big pharma in medicine-making and the hassle of dealing with protective pa ...
APR 16, 2020
APR 16, 2020
The Unseen Barriers Surrounding Pancreatic Cancer
Pancreatic cancer is one of the deadliest cancers in the world. With a poor five year prognosis and lack of effective tr ...
APR 20, 2020
Cell & Molecular Biology
APR 20, 2020
Worst COVID-19 Cases May be Caused by Immune Cell Overactivity
The SARS-CoV-2 virus causea huge range of symptoms, and researchers are learning more about the worst cases, which may h ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the World’s attention. COVID- ...
APR 22, 2020
APR 22, 2020
Scientists Engineer Custom Antiviral Receptors to Fight COVID-19
The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are e ...
Loading Comments...